KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Interest Expenses (2016 - 2025)

Boston Scientific's Interest Expenses history spans 17 years, with the latest figure at $90.0 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 12.5% year-over-year to $90.0 million; the TTM value through Dec 2025 reached $349.0 million, up 14.43%, while the annual FY2025 figure was $349.0 million, 14.43% up from the prior year.
  • Interest Expenses for Q4 2025 was $90.0 million at Boston Scientific, up from $87.0 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $279.0 million in Q1 2022 and bottomed at $63.0 million in Q3 2022.
  • The 5-year median for Interest Expenses is $79.5 million (2024), against an average of $86.5 million.
  • The largest annual shift saw Interest Expenses soared 240.24% in 2022 before it plummeted 76.7% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $87.0 million in 2021, then dropped by 26.44% to $64.0 million in 2022, then changed by 0.0% to $64.0 million in 2023, then increased by 25.0% to $80.0 million in 2024, then grew by 12.5% to $90.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Interest Expenses are $90.0 million (Q4 2025), $87.0 million (Q3 2025), and $90.0 million (Q2 2025).